ArticlePloS one2026

A novel design using a virtual control group to evaluate non-inferiority of nevirapine and lamivudine dual maintenance in HIV therapy.

Alessandro Suter et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.